Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma
Ahmed Glaucoma Valve Alone,With Amniotic Membrane or With MMC for Treatment of Refractory Glaucoma
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This randomized, controlled trial (RCT) compares the efficacy and safety of Ahmed Glaucoma Valve (AGV) implantation alone, with 3 minutes MMC application or with a single layer coverage of amniotic membrane. Outcomes include intraocular eye pressure (IOP), postoperative glaucoma medication and complications. AGV implantation site will be superior or inferior based on indication and these groups will be randomized separately.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2009
CompletedFirst Posted
Study publicly available on registry
May 6, 2009
CompletedMay 6, 2009
May 1, 2009
May 4, 2009
May 4, 2009
Conditions
Study Arms (3)
Ahmed Glaucoma Valve (AGV) alone
EXPERIMENTALAGV plus MMC
EXPERIMENTALAGV plus amniotic membrane coverage
EXPERIMENTALInterventions
AGV implantation
single layer coverage of amniotic membrane
Eligibility Criteria
You may qualify if:
- patients with refractory glaucoma
You may not qualify if:
- children under 7 years old
- adults above 75 years old
- uncooperative patients
- patients underwent the operation for second time
- patients with major operation with AGV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ophthalmic Research Center
Tehran, Tehran Province, 166666, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Purpose
- TREATMENT
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 4, 2009
First Posted
May 6, 2009
Last Updated
May 6, 2009
Record last verified: 2009-05